revis popgen pipelin remain robust time biggest factor
popul genom project check suggest opportun remain robust
grown sinc last check year ago despit delay releas fund
overal sequenc spend estim increas previou
forecast recal cut guidanc believ
relat popgen consist find check bottom
line though project ramp slower expect opportun remain larg
continu grow
note version correct impli revenu second bullet
popgen updat forward estim base declar avail
alloc fund sampl volum type sequenc conduct whole
genom vs exom addit ad estim even revis
larg project out-year estim downward significantli easi
comp suggest time impli signific ramp investor may
understand skeptic ramp given delay although recent
fund releas nh other support uk biobank increment
posit total popgen estim increas total found
activ project line manag suggest on-going
publicli announc project project databas larg scale human
sequenc program thu believ use illumina novaseq system
implic recal dtc guidanc cut total
cut remain two compon popgen lower non-high-
throughput sequenc revenu includ delay partner program
believ total popgen cut reflect time delay vs alter
program obvious biggest risk project time delay
larg project less within control say sell increment
instrument exist custom receiv grant spend us expect
begin ramp vs prior expect plan sequenc
genom first year million total estim revenu main
near term popgen program uk biobank us gel phase could repres
revenu grow
pleas see popseq databas page
lead provid genet research technolog
price close septemb
on-going ep
net cash-per-share
adopt govern fund
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
countri origin
number sampl
type sequenc
array whole exom whole genom
year
year
goal
target
major project remain
sequenc
phase
japan initi
genom korea ulsan
genom england nh gel
us research program
nebula genom emd serono
mayo regeneron
heredigen decod
atla strive summit
year delay
fund present
year
year phase
first year
heart lung
phase
initi
studi addit
like mix exom whole genom ion
beyond
launch octob sequenc
year
launch project seqyuenc
start recruit peopl
call said project sequenc
phase
year
still work
sequenc sequenc
remain end
like mix array target sequenc
whole exom whole genom
na like exom wg
mostli array exom genom
biobank may sequenc
mostli exom genom
sampl analyz
enrol limit fund
na like exom wg
genom atla strive studi
complet initi summit studi
bring total
sequenc jan phase
phase via
sequenc
sequenc
finish
sequenc mid
complet sampl mid phase
pjc estim compani websit
estim spend
page
